Original language | English (US) |
---|---|
Pages (from-to) | 898-900 |
Number of pages | 3 |
Journal | JAMA - Journal of the American Medical Association |
Volume | 321 |
Issue number | 9 |
DOIs | |
State | Published - Mar 5 2019 |
Funding
Conflict of Interest Disclosures: Dr Tsai reported being the chair of the education committee, Dr Apovian the president, and Dr Kaplan on the executive council of the Obesity Society. Dr Apovian reported receiving personal fees from Nutrisystem, Zafgen, Sanofi-Aventis, Orexigen, GI Dynamics, Takeda, Scientific Intake, Xeno Biosciences, Rhythm Pharmaceuticals, Eisai, EnteroMedics, Bariatrix, and NovoNordisk; receiving grants from Aspire Bariatrics, GI Dynamics, Myos, Takeda, Vela Foundation, Coherence Lab, Energesis, the National Institutes of Health, and the Patient-Centered Outcomes Research Institute; and having past stock ownership in Science-Smart LLC. Funding/Support: This study is based on work supported by grant R01GM112938 from the National Institutes of Health, grant 1747631 from the National Science Foundation, and funding from the Northwestern Institution on Complex Systems and the Kellogg School of Management.
ASJC Scopus subject areas
- General Medicine